Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

Nature Medicine

Volumn 10, Issue 2, 2004, Pages 187-192

  Heikenwalder, Mathias ^a   Polymenidou, Magdalini ^a   Junt, Tobias ^b   Sigurdson, Christina ^a   Wagner, Hermann ^c   Akira, Shizuo ^d   Zinkernagel, Rolf ^b   Aguzzi, Adriano ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDYLGUANOSYL OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE DERIVATIVE; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; CYTOKINE; DNA BINDING PROTEIN; IMMUNOGLOBULIN; IMMUNOLOGICAL ADJUVANT; LEUKOCYTE ANTIGEN; OLIGODEOXYRIBONUCLEOTIDE; TLR9 PROTEIN, MOUSE;

ARTICLE; ASCITES; B LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLICULAR DENDRITIC CELL; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LIVER NECROSIS; LYMPH FOLLICLE; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BLOOD; C57BL MOUSE; CPG ISLAND; CYTOLOGY; GENETICS; HISTOLOGY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOID TISSUE; METABOLISM; MOUSE MUTANT; ORGAN SIZE; PATHOLOGY; PRION; T LYMPHOCYTE;

MAMMALIA; PROKARYOTA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CPG ISLANDS; CYTOKINES; DNA-BINDING PROTEINS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULINS; IMMUNOSUPPRESSION; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGODEOXYRIBONUCLEOTIDES; ORGAN SIZE; PRIONS; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9;

EID: 0842343142     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm987     Document Type: Article

References (30)

1. Krieg, A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709-760 (2002).
2. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
3. Sethi, S., Lipford, G., Wagner, H. & Kretzschmar, H. Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet 360, 229-230 (2002).
4. Klein, M.A. et al. A crucial role for B cells in neuroinvasive scrapie. Nature 390, 687-690 (1997).
5. Aucouturier, P. et al. Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J. Clin. Invest. 108, 703-708 (2001).
6. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143-150 (1998).
7. Hacker, H. et al. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med. 192, 595-600 (2000).
8. Prinz, M. et al. Prion pathogenesis in the absence of Toll-like receptor signalling. EMBO Rep. 4, 195-199 (2003).
9. Montrasio, F. et al. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 1257-1259 (2000).
10. Aguzzi, A., Montrasio, F. & Kaeser, P.S. Prions: health scare and biological challenge. Nat. Rev. Mol. Cell. Biol. 2, 118-126 (2001).
11. Sparwasser, T. et al. Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. J. Immunol. 162, 2368-2374 (1999).
12. Davila, E., Velez, M.G., Heppelmann, C.J. & Celis, E. Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartment. Blood 100, 2537-2545 (2002).
13. Schmidt, U., Wagner, H. & Miethke, T. CpG-DNA upregulates the major acute-phase proteins SAA and SAP. Cell. Microbiol. 1, 61-67 (1999).
14. Rothe, J. et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798-802 (1993).
15. Muller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921 (1994).
16. Alexopoulou, L., Holt, A.C., Medzhitov, R. & Flavell, R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732-738 (2001).
17. Gilch, S. et al. Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells. J. Biol. Chem. 278, 18524-18531 (2003).
18. Ochsenbein, A.F. et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286, 2156-2159 (1999).
19. Oxenius, A., Martinic, M.M., Hengartner, H. & Klenerman, P. CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. J. Virol. 73, 4120-4126 (1999).
20. Vabulas, R.M., Pircher, H., Lipford, G.B., Hacker, H. & Wagner, H. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses. J. Immunol. 164, 2372-2378 (2000).
21. Binder, D., Fehr, J., Hengartner, H. & Zinkernagel, R.M. Virus-induced transient bone marrow aplasia: major role of interferon-α /β during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 185, 517-530 (1997).
22. Riviere, Y., Gresser, I., Guillon, J.C. & Tovey, M.G. Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice. Proc. Natl. Acad. Sci. USA 74, 2135-2139 (1977).
23. Odermatt, B., Eppler, M., Leist, T.P., Hengartner, H. & Zinkernagel, R.M. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc. Natl. Acad. Sci. USA 88, 8252-8256 (1991).
24. Davila, E. & Celis, E. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity. J. Immunol. 165, 539-547 (2000).
25. Martin, F., Oliver, A.M. & Kearney, J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14, 617-629 (2001).
26. Fehr, T. et al. Correlation of anti-viral B cell responses and splenic morphology with expression of B cell-specific molecules. Int. Immunol. 12, 1275-1284 (2000).
27. Storni, T. et al. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles. J. Immunol. 168, 2880-2886 (2002).
28. -/- mice. J. Immunol. 164, 768-778 (2000).
29. Prinz, M. et al. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425, 957-962 (2003).
30. Heppner, F.L. et al. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294, 178-182 (2001).